Regencell Bioscience Holdings (RGC) Shares Outstanding (2020 - 2025)

Regencell Bioscience Holdings (RGC) has 6 years of Shares Outstanding (Entity) data on file, last reported at $494.5 million in Q4 2025.

• Quarterly Shares Outstanding (Entity) changed N/A year-over-year to $494.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $494.5 million (changed N/A YoY) and the FY2025 annual result came in at $494.5 million, changed 0.0% from the prior year.
• Shares Outstanding (Entity) was little changed at $494.5 million in Q4 2025, from $494.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $494.5 million in Q2 2022 to a low of $380.0 million in Q2 2021.
• A 5-year average of $475.4 million and a median of $494.5 million in 2022 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) changed 0.0% — and 2022, when it jumped 30.13%.
• Tracing RGC's Shares Outstanding (Entity) over 5 years: stood at $380.0 million in 2021, then surged by 30.13% to $494.5 million in 2022, then changed by 0.0% to $494.5 million in 2023, then changed by 0.0% to $494.5 million in 2024, then changed by 0.0% to $494.5 million in 2025.
• The last three Shares Outstanding (Entity) figures came in at $494.5 million (Q4 2025), $494.5 million (Q2 2025), and $494.5 million (Q2 2024), per Business Quant data.